000 06072cam a2200433Ii 4500
001 95124
003 ES-MaUEC
005 20230102112648.0
006 m o d
007 cr cnu|||unuuu
008 170103s2017 sz o 000 0 eng d
020 _a3319498649
_q(electronic bk.)
020 _a9783319498645
_q(electronic bk.)
020 _z3319498630
020 _z9783319498638
035 _a(OCoLC)967512020
_z(OCoLC)967571552
_z(OCoLC)974651198
_z(OCoLC)1005781061
_z(OCoLC)1011853480
040 _aN$T
_cN$T
_dIDEBK
_dEBLCP
_dGW5XE
_dN$T
_dYDX
_dAZU
_dUAB
_dOCLCF
_dCOO
_dUPM
_dIOG
_dESU
_dJBG
_dIAD
_dICW
_dOHI
_dICN
_dMERER
_dOTZ
_dOCLCQ
_dVT2
_dU3W
_dES-MaUEC
_bspa
050 4 _aRC280.B7
_b2017 EB
245 0 0 _aMalignant brain tumors :
_bstate-of-the-art treatment
_cJennifer Moliterno Gunel, Joseph M Piepmeier, Joachim M. Baehring, editors.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPreface; Contents; Contributors; Molecular and Clinical Characterization of Gliomas; 1 Use of Advanced Neuroimaging (fMRI, DTI/Tractography) in the Treatment of Malignant Gliomas; Functional MRI; Task-Based fMRI; Resting State fMRI; Motor Mapping Using fMRI; Supplementary Motor Area; Language fMRI; Language Lateralization; Language Localization; Technical Considerations; Diffusion Tractography; Cortico-Spinal Tract; Arcuate Fasciculus; Visual Projections; Limitations; References; 2 Molecular Neuropathology and the Ontogeny of Malignant Gliomas; Introduction.
505 8 _a2016 WHO Classification-Integrated Diagnostics; Diffuse Astrocytic and Oligodendroglial Gliomas; Histological Profiles of Diffuse Astrocytic and Oligodendroglial Tumors; Diffuse Astrocytic Tumors; Diffuse Oligodendroglial Tumors; Diffuse Oligoastrocytomas; Molecular Profiles of Diffuse Astrocytic and Oligodendroglial Tumors; Isocitrate Dehydrogenase (IDH) Mutations; Co-deletion of 1p/19q; MGMT Methylation Status; Role of Epidermal Growth Factor Receptor (EGFR) Pathway Aberrations; Diffuse Midline Glioma; Ependymal Tumors; Molecular Profiles of Ependymal Tumors; Disclosures; References.
505 8 _a3 Personalized Medicine Through Advanced Genomics; Introduction; Advanced Genomic Technologies; Whole-Genome Sequencing (WGS) and Whole-Exome Sequencing (WES); Bioinformatic Analysis of NGS; Gene Expression Studies; Proteomics; Genomic Approaches to Personalized Medicine; Insights on Malignant Brain Tumors from Genomic Studies; Glioblastoma Multiforme; Medulloblastoma; Meningioma; Tumor Heterogeneity and the Need for Personalized Approaches; Future Directions and Challenges; References; Surgery: Maximizing the Extent of Tumor Resection.
505 8 _a4 The Usefulness of Stereotactic Neuronavigation Along with Intraoperative Imaging in Malignant Brain Tumor Surgery; Introduction; Stereotactic Neuronavigation; Intraoperative Ultrasound (iUS); Intraoperative Magnetic Resonance Imaging (iMRI); Intraoperative Angiography (iA); Summary; References; 5 Mapping the Brain for Primary Brain Tumor Surgery; Introduction; Preoperative Mapping; Preoperative Cortical Methods; Task-Based fMRI (T-fMRI); Rest-Based fMRI (R-fMRI); rTMS: Motor/Language; Preoperative Axonal Mapping; Intraoperative Mapping; Cortical Mapping Under General Anesthesia.
505 8 _aMotor: DES Versus Train of Five; Non-motor Functions: Cortico-Cortical Evoked Potentials; Cortical Mapping in Awake Condition; Sensori-Motor Functions; Primary Visual Areas; Language; Spatial Consciousness; Calculation; Double Task; Mentalizing; Other Self-reported Effects of Stimulations; Axonal Mapping Under General Anesthesia; Motor: DES Versus Train of Five; Non-motor Functions: ACEPs; Axonal Mapping in Awake Patients; Motor Functions; Language Function; Visual Functions; Spatial Consciousness; Mentalizing; Mental Calculation; Plasticity and Remapping; Conclusions; References.
520 3 _aThis text addresses all aspects of patient evaluation and care. This includes new findings in imaging that provide a better understanding of the extent of the lesion as well as its relationship with critical neuroanatomic function. The evolution of intraoperative imaging, functional brain mapping, and technology to identify tumor from brain is covered. This has significantly improved the ability of surgeons to more safely and aggressively remove tumors. More importantly, a better understanding of tumor biology and genomics has created an opportunity to significantly revise tumor classification and better select optimal therapy for individual patients. The text covers novel and innovative treatment options including immunotherapy, tumor vaccines, antiangiogenic agents, and personalized cancer treatment. In addition, novel agent delivery techniques are covered to offer the potential for increasing the effectiveness of treatment by delivering active agents directly where they are needed most. Malignant Brain Tumors: State-of-the-Art Treatment provides a comprehensive overview of treatment for malignant gliomas, and will prove useful by updating physicians on new therapeutic paradigms and what is on the horizon for the near future. This text will be informative for surgeons, oncologists, neurologists, residents and students who treat these patients, as well as those who are training for a career in managing patients with these challenging tumors.
650 7 _aCerebro
_xCancer.
_2embne
_0(OCoLC)fst00837592
_0
_9139532
700 1 _aBaehring, Joachim M.,
_eeditor literario
700 1 _aGunel, Jennifer Moliterno,
_eeditor literario
700 1 _aPiepmeier, J. M.,
_eeditor literario
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-49864-5
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c95124
_d95124
_x1